Emily has a deep understanding of life sciences-related issues, with a particular focus on the regulation of compounded drugs across both the human and animal health spheres. She is a recognized industry advocate and thought leader who actively engages with regulators, legislators, and stakeholders to advance the interests of compounding pharmacies and outsourcing facilities. She also advises clients on due diligence, change of ownership, regulatory approvals, and related issues in connection with health care transactions. Emily's mission is to enable her clients to achieve their business goals while ensuring compliance and quality in the delivery of health care services.

When not advocating for her clients in the life sciences sector, Emily serves as the Chair of the Chicago office’s Women’s Initiative Network, which is designed to ensure that women not only have a place at the table, but that they are also often at the head of the table.